On The Pulse


Associate Editor Lindsey Carr sat down with Gary Schoolnik, MD, Visby Medical’s Chief Medical Officer, to learn more about the device’s functionality and application.

Watch Video

The U.S. Food and Drug Administration (FDA) has issued 501(k) clearance for Visby Medical’s Sexual Health Click Test, a single-use, instrument-free polymerase chain reaction (PCR) diagnostic test for sexually transmitted infections (STI).

View Article

The COVID-19 pandemic has affected the global community in countless ways, some of which are more obvious than others.

View Article

Featuring Dr. Krychman and Nurse Barb Dehn.

Listen to Podcast

The data suggest that both SCD providers and AYA need better evidence and educational resources for contraception, as well as coordinated SRH counseling, according to researchers.

View Article

The CDC updated its guidelines for diagnosing and treating STIs, which included updates on the diagnosis and treatment of bacterial vaginosis (BV) in pregnant and nonpregnant women.

View Article

The Centers for Disease Control and Prevention (CDC) updated its guidelines for the treatment of sexually transmitted infections (STIs), notably for Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and pelvic inflammatory disease (PID).

View Article

For cervical cancer screening, human papillomavirus (HPV)–based screening modalities detect significantly more abnormal cervical cells than traditional liquid-based cytology (LBC) approaches, according to a study in JAMA Network Open.

View Article

There are many reasons why a caregiver may refuse to have his or her child receive the human papillomavirus (HPV) vaccine, including safety concerns. A research letter examines whether those concerns have increased.

View Article

“Over the past several years, a growing number of companies have been providing contraception through online platforms, but there has been very little research on these businesses,” said principal investigator Brittni Frederiksen, MPH, PhD, a senior policy analyst at KFF in San Francisco.

View Article